Results
eNauka >
Results >
Clinical potential of circulating tumor DNA (ctDNA)-based molecular response (MR) and baseline blood-based tumor mutational burden (bTMB) for monitoring response to firstline (1L) chemoimmunotherapy in advanced squamous non-small cell lung cancer (sqNSCLC
| Title: | Clinical potential of circulating tumor DNA (ctDNA)-based molecular response (MR) and baseline blood-based tumor mutational burden (bTMB) for monitoring response to firstline (1L) chemoimmunotherapy in advanced squamous non-small cell lung cancer (sqNSCLC | Authors: | Ciardiello, F; Feng, Z; Smith, NR; Andric, Zoran G   ; Shell, S; Yablonovitch, A; Guezel, G; Scheuenpflug, J |
Issue Date: | 2022 | Publication: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 33 br. 7 str. S1050-S1051 | DOI: | 10.1016/j.annonc.2022.07.1217 | WoS-ID: | 000866211601356 | URI: | https://enauka.gov.rs/handle/123456789/823163 | Project: | Merck | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.